D.J.D. has served as a consultant or speaker within the past 12 months to Altimmune, Amgen, Arrowhead, AstraZeneca, Boehringer Ingelheim, Kallyope, Merck Research Laboratories, Novo Nordisk Inc., Pfizer Inc and Zealand Pharma. Neither D.J.D. nor his family members hold issued stock directly or indirectly in any of these companies. D.J.D. holds non-exercised options in Kallyope.